Published in Am J Clin Nutr on January 13, 2010
Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care (2013) 4.85
Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ Res (2010) 1.89
Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr (2010) 1.47
Redox-dependent anti-inflammatory signaling actions of unsaturated fatty acids. Annu Rev Physiol (2013) 1.05
Atherosclerosis, dyslipidemia, and inflammation: the significant role of polyunsaturated Fatty acids. ISRN Inflamm (2013) 0.97
(n-3) Fatty Acids: Clinical Trials in People with Type 2 Diabetes. Adv Nutr (2010) 0.95
Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment. Rev Diabet Stud (2013) 0.91
Effects of insulin glargine versus metformin on glycemic variability, microvascular and beta-cell function in early type 2 diabetes. Acta Diabetol (2013) 0.89
Effect of fish oil supplementation on fasting vascular endothelial function in humans: a meta-analysis of randomized controlled trials. PLoS One (2012) 0.87
Effects of Olive Oil on Markers of Inflammation and Endothelial Function-A Systematic Review and Meta-Analysis. Nutrients (2015) 0.86
The effects of n-3 long-chain polyunsaturated fatty acid supplementation on biomarkers of kidney injury in adults with diabetes: results of the GO-FISH trial. Diabetes Care (2012) 0.86
Nutritional regulation of insulin secretion: implications for diabetes. Clin Biochem Rev (2012) 0.86
En Balance participants decrease dietary fat and cholesterol intake as part of a culturally sensitive Hispanic diabetes education program. Diabetes Educ (2011) 0.83
DHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity. Expert Opin Drug Discov (2012) 0.81
Type 2 diabetes, PUFAs, and vitamin D: their relation to inflammation. J Immunol Res (2014) 0.80
Dietary fish oil substitution alters the eicosanoid profile in ankle joints of mice during Lyme infection. J Nutr (2012) 0.80
Supplementation with a juice powder concentrate and exercise decrease oxidation and inflammation, and improve the microcirculation in obese women: randomised controlled trial data. Br J Nutr (2013) 0.80
Role of CYP1A1 in modulating the vascular and blood pressure benefits of omega-3 polyunsaturated fatty acids. J Pharmacol Exp Ther (2014) 0.80
Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia. PLoS One (2016) 0.80
Omega-3s and cardiovascular health. Ochsner J (2014) 0.79
Omega-3 Polyunsaturated Fatty Acids: Structural and Functional Effects on the Vascular Wall. Biomed Res Int (2015) 0.77
Impact of DHA on metabolic diseases from womb to tomb. Mar Drugs (2014) 0.76
Redox-sensitive induction of Src/PI3-kinase/Akt and MAPKs pathways activate eNOS in response to EPA:DHA 6:1. PLoS One (2014) 0.75
A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes. Cardiovasc Diabetol (2017) 0.75
Effects of vitamin A, C and E, or omega-3 fatty acid supplementation on the level of paraoxonase and arylesterase activity in streptozotocin-induced diabetic rats: an investigation of activities in plasma, and heart and liver homogenates. Singapore Med J (2016) 0.75
Omega 3 Fatty Acids Supplementation and Oxidative Stress in HIV-Seropositive Patients. A Clinical Trial. PLoS One (2016) 0.75
Do n-3 fatty acids improve microvascular function in subjects with type 2 diabetes mellitus? Am J Clin Nutr (2010) 0.75
Role of free fatty acids in endothelial dysfunction. J Biomed Sci (2017) 0.75
Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr (2009) 2.71
An evaluation of diabetes self-management applications for Android smartphones. J Telemed Telecare (2012) 1.99
Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects. Diabetes Care (2007) 1.97
Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches. Surv Ophthalmol (2009) 1.92
Women and heart disease: the role of diabetes and hyperglycemia. Arch Intern Med (2004) 1.63
Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr (2007) 1.56
Effects of a rapeseed oil-enriched hypoenergetic diet with a high content of α-linolenic acid on body weight and cardiovascular risk profile in patients with the metabolic syndrome. Br J Nutr (2012) 1.47
HYPERGLYCEMIA MANAGEMENT IN PATIENTS WITH POSTTRANSPLANTATION DIABETES. Endocr Pract (2015) 1.39
Circulating calcitriol concentrations and total mortality. Clin Chem (2009) 1.38
SPP1 promoter polymorphisms: identification of the first modifier gene for pseudoxanthoma elasticum. Clin Chem (2007) 1.33
Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care (2006) 1.31
Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin Chem (2005) 1.15
Pseudoxanthoma elasticum: genetic variations in antioxidant genes are risk factors for early disease onset. Clin Chem (2007) 1.14
Advanced meter features improve postprandial and paired self-monitoring of blood glucose in individuals with diabetes: results of the Actions with the CONTOUR Blood Glucose Meter and Behaviors in Frequent Testers (ACT) study. Diabetes Technol Ther (2012) 1.13
Poor outcome in end-stage heart failure patients with low circulating calcitriol levels. Eur J Heart Fail (2008) 1.06
Vascular endothelial growth factor gene polymorphisms as prognostic markers for ocular manifestations in pseudoxanthoma elasticum. Hum Mol Genet (2009) 1.05
Attenuation correction of myocardial SPECT perfusion images with low-dose CT: evaluation of the method by comparison with perfusion PET. J Nucl Med (2005) 1.04
Human xylosyltransferase II is involved in the biosynthesis of the uniform tetrasaccharide linkage region in chondroitin sulfate and heparan sulfate proteoglycans. J Biol Chem (2006) 1.03
Mutational analysis of the ABCC6 gene and the proximal ABCC6 gene promoter in German patients with pseudoxanthoma elasticum (PXE). Hum Mutat (2006) 0.99
A randomized controlled trial on the efficacy of carbohydrate-reduced or fat-reduced diets in patients attending a telemedically guided weight loss program. Cardiovasc Diabetol (2009) 0.98
Regulation of mitochondrial morphology and function by O-GlcNAcylation in neonatal cardiac myocytes. Am J Physiol Regul Integr Comp Physiol (2011) 0.98
Cloning and recombinant expression of active full-length xylosyltransferase I (XT-I) and characterization of subcellular localization of XT-I and XT-II. J Biol Chem (2006) 0.98
The local calcification inhibitor matrix Gla protein in pseudoxanthoma elasticum. Clin Biochem (2008) 0.98
Calcitriol deficiency and 1-year mortality in cardiac transplant recipients. Transplantation (2009) 0.97
Good manufacturing practice-compliant expansion of marrow-derived stem and progenitor cells for cell therapy. Cell Transplant (2007) 0.96
Cardiovascular complications in diabetes: targets and interventions. Diabetes Care (2008) 0.93
Quantitative determination of the glycosaminoglycan Delta-disaccharide composition of serum, platelets and granulocytes by reversed-phase high-performance liquid chromatography. J Chromatogr A (2008) 0.93
Novel mutations in the ABCC6 gene of German patients with pseudoxanthoma elasticum. Hum Biol (2005) 0.92
Gene expression profiling of ABC transporters in dermal fibroblasts of pseudoxanthoma elasticum patients identifies new candidates involved in PXE pathogenesis. Lab Invest (2008) 0.92
Decorin GAG synthesis and TGF-β signaling mediate Ox-LDL-induced mineralization of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2011) 0.91
AGEs and methylglyoxal induce apoptosis and expression of Mac-1 on neutrophils resulting in platelet-neutrophil aggregation. Thromb Res (2007) 0.90
Pathobiology and cell interactions of platelets in diabetes. Diab Vasc Dis Res (2005) 0.90
Differences in gene expression of human xylosyltransferases and determination of acceptor specificities for various proteoglycans. Biochem Biophys Res Commun (2009) 0.89
New ABCC6 gene mutations in German pseudoxanthoma elasticum patients. J Mol Med (Berl) (2004) 0.88
Human xylosyltransferase I: functional and biochemical characterization of cysteine residues required for enzymic activity. Biochem J (2005) 0.88
Coronary revascularization in diabetic patients: off-pump versus on-pump surgery. Ann Thorac Surg (2013) 0.88
Transforming growth factor beta1-regulated xylosyltransferase I activity in human cardiac fibroblasts and its impact for myocardial remodeling. J Biol Chem (2007) 0.86
Measurement of fibrosis marker xylosyltransferase I activity by HPLC electrospray ionization tandem mass spectrometry. Clin Chem (2006) 0.86
Skin autofluorescence increases postprandially in human subjects. Diabetes Technol Ther (2008) 0.86
Adiponectin decreases postprandially following a heat-processed meal in individuals with type 2 diabetes: an effect prevented by benfotiamine and cooking method. Diabetes Care (2007) 0.85
Measurement of mycophenolic acid and its glucuronide using a novel rapid liquid chromatography-electrospray ionization tandem mass spectrometry assay. Clin Biochem (2008) 0.85
Impact of polymorphisms in the genes encoding xylosyltransferase I and a homologue in type 1 diabetic patients with and without nephropathy. Kidney Int (2005) 0.85
Mitochondrial 8-oxoguanine glycosylase decreases mitochondrial fragmentation and improves mitochondrial function in H9C2 cells under oxidative stress conditions. Am J Physiol Cell Physiol (2013) 0.84
A molecular mechanism for therapeutic effects of cGMP-elevating agents in pulmonary arterial hypertension. J Biol Chem (2013) 0.84
The formation of extracellular matrix during chondrogenic differentiation of mesenchymal stem cells correlates with increased levels of xylosyltransferase I. Stem Cells (2006) 0.84
Platelet activation markers in patients with heart assist device. Artif Organs (2005) 0.84
Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients. J Mol Med (Berl) (2009) 0.83
The xylosyltransferase I gene polymorphism c.343G>T (p.A125S) is a risk factor for diabetic nephropathy in type 1 diabetes. Diabetes Care (2006) 0.83
High-level expression and purification of human xylosyltransferase I in High Five insect cells as biochemically active form. Biochem Biophys Res Commun (2003) 0.83
PLA1A2 platelet polymorphism predicts mortality in prediabetic subjects of the population based KORA S4-Cohort. Cardiovasc Diabetol (2014) 0.82
Analysis of MMP2 promoter polymorphisms in patients with pseudoxanthoma elasticum. Clin Chim Acta (2010) 0.82
Simultaneous determination and validated quantification of human insulin and its synthetic analogues in human blood serum by immunoaffinity purification and liquid chromatography-mass spectrometry. Anal Bioanal Chem (2012) 0.82
Identification and characterization of the human xylosyltransferase I gene promoter region. J Biol Chem (2009) 0.82
The xylosyltransferase Iota gene polymorphism c.343G>T (p.A115S) is associated with decreased serum glycosaminoglycan levels. Clin Biochem (2008) 0.81
Heterologous expression and biochemical characterization of soluble human xylosyltransferase II. Biochem Biophys Res Commun (2007) 0.81
Fundus autofluorescence in Pseudoxanthoma elasticum. Retina (2009) 0.81
Quantitative determination and comparison of the glycosaminoglycan Delta-disaccharide composition in 22 different human cell lines. Cell Biol Int (2009) 0.80
Diabetes, glucose control, glucose lowering medications, and cancer risk: a 10-year population-based historical cohort. BMC Cancer (2012) 0.80
Sex hormones and bariatric surgery in men. Gend Med (2011) 0.80
Diabetic cardiomyopathy--to take a long story serious. Herz (2010) 0.80
Impact of GLO1 knock down on GLUT4 trafficking and glucose uptake in L6 myoblasts. PLoS One (2013) 0.80
Age dependent assessment of TFPI levels in follicular fluid of women undergoing IVF. Clin Chim Acta (2005) 0.80
Advanced glycation end products strongly activate platelets. Eur J Nutr (2009) 0.80
Should we be more aggressive in the therapy against cardiovascular risk factors? Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill? Diabetes Care (2008) 0.80
Gender medicine in the field of endocrinology. Gend Med (2010) 0.80
Increased levels of xylosyltransferase I correlate with the mineralization of the extracellular matrix during osteogenic differentiation of mesenchymal stem cells. Matrix Biol (2007) 0.79
Genetic variations in the human TFPI-2 gene and its promoter region by denaturing high performance liquid chromatography. Thromb Res (2004) 0.79
Effect of mental and physical stress on platelet activation markers in depressed patients and healthy subjects: a pilot study. Psychiatry Res (2004) 0.79
Functional changes in microcirculation during hyperbaric and normobaric oxygen therapy. Undersea Hyperb Med (2010) 0.79
Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines. Ann N Y Acad Sci (2008) 0.79
Analysis of sequence variations in the promoter region of the human tissue factor pathway inhibitor 2 gene in apoplectic patients and blood donors. Ann Hematol (2005) 0.79
Atherogenesis and atherothrombosis--focus on diabetes mellitus. Best Pract Res Clin Endocrinol Metab (2009) 0.78
Human xylosyltransferase I and N-terminal truncated forms: functional characterization of the core enzyme. Biochem J (2006) 0.78